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Abstract
The joint modeling of longitudinal and time-to-event data is an active area of statistics re-
search that has received a lot of attention in the recent years. More recently, a new and
attractive application of this type of models has been to obtain individualized predictions of
survival probabilities and/or of future longitudinal responses. The advantageous feature of
these predictions is that they are dynamically updated as extra longitudinal responses are
collected for the subjects of interest, providing real time risk assessment using all recorded
information. The aim of this paper is two-fold. First, to highlight the importance of mod-
eling the association structure between the longitudinal and event time responses that can
greatly influence the derived predictions, and second, to illustrate how we can improve the
accuracy of the derived predictions by suitably combining joint models with different asso-
ciation structures. The second goal is achieved using Bayesian model averaging, which, in
this setting, has the very intriguing feature that the model weights are not fixed but they are
rather subject- and time-dependent, implying that at different follow-up times predictions
for the same subject may be based on different models.
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1 Introduction
In recent years it has been recognized that personalized medicine forms the future of medical
care. This has increased interest in development of prognostic models for many different
types of diseases. Examples are numerous and include, prognostic models for various types
of cancer, such as breast and prostate cancer; risk scores for cardiovascular diseases, such as
the Framingham score; and prognostic models applied in AIDS research to assess the risk
of HIV infected patients. However, even though there is a wealth of patient data available,
the majority of prognostic models in the literature provide risk predictions using only a
small portion of the recorded information. This is especially true for patient outcomes
that are repeatedly measured in time where typically only the last measurement is utilized.
A clear advantage of such simple models is that they can be applied in everyday clinical
practice. However, an important limitation is that valuable information is discarded, which if
appropriately used, could offer a better insight into the dynamics of the disease’s progression.
In particular, an inherent characteristic of many medical conditions, such as those described
above, is their dynamic nature. That is, the rate of progression is not only different from
patient to patient but also dynamically changes in time for the same patient. Hence, it is
medically relevant to investigate whether repeated measurements of a biomarker can provide
a better understanding of disease progression and a better prediction of the risk for the event
of interest than a single biomarker measurement (e.g., at baseline or the last available).
It is evident that markers with this capability would become a valuable tool in everyday
medical practice, because they would provide physicians with a better understanding of
disease progression for a particular patient, and allow them to make more informed decisions.
This is also the aim of our motivating case study on patients who underwent aortic valve
allograft implantation, described in detail in Section 2. In particular, even though human
tissue valves have some advantages, they are also more susceptible to tissue degeneration
and require re-intervention. Hence, cardiologists wish to use an accurate prognostic tool that
will inform them about the future prospect of a patient with a human tissue valve in order
to adjust medical care and postpone re-operation and/or death.
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Motivated by the Aortic Valve case study, this paper aims to provide a flexible modeling
framework for producing risk predictions that utilize all available patient information. We
will explicitly model the longitudinal history of each subject by basing our developments on
the framework of joint models for longitudinal and time-to-event data (Faucett and Thomas
1996; Wulfsohn and Tsiatis 1997; Henderson et al. 2000; Tsiatis and Davidian 2004; Guo
and Carlin 2004; Rizopoulos 2012). In particular, an attractive use of joint models is to
derive dynamic predictions for either the survival or longitudinal outcomes (Yu et al. 2008;
Proust-Lima and Taylor 2009; Rizopoulos 2011). The advantageous features of these pre-
dictions are that they are individualized, are updated as extra longitudinal information is
recorded for each subject, and are based on all past values of the longitudinal outcome.
Our novel contributions are two-fold. First, the subjects under consideration often exhibit
complex longitudinal trajectories with nonlinearities and plateaus. In these settings, it is
relevant to consider which characteristics of a subject’s trajectory best predict the event of
interest. To this end, we will investigate how predictions are affected by assuming different
types of association structure between the longitudinal and event time processes. We go
beyond the standard formulation of joint models (Henderson et al. 2000), and we postulate
functional forms that allow the rate of increase/decrease of the longitudinal outcome or a
suitable summary of the whole longitudinal trajectory to determine the risk for an event.
The consideration of competing association structures to describe the link between the two
processes raises the issue of model uncertainty, which is typically ignored in prognostic mod-
eling. Motivated by this, our second contribution is to derive predictions based not on a
single model but on a collection of models simultaneously, combining them using Bayesian
model averaging. As we will show later this approach bases predictions are based on the
available data of a subject and the model weights are both individual- and time-dependent.
The rest of the paper is organized as follows. Section 2 gives a background on aor-
tic allograft implantation and describes the Aortic Valve dataset that motivates this re-
search. Section 3 briefly introduces the joint modeling framework, presents estimation under
a Bayesian approach and shows how dynamic individualized predictions can be derived under
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a joint model. Section 4 introduces several formulations of the association structure between
the longitudinal and survival processes. Section 5 presents the Bayesian model averaging
methodology to combine predictions, and Section 6 illustrates the use of this technique in
the Aortic Valve dataset. Section 7 refers to the results of a simulation study, and Section 8
concludes the paper.
2 Background on the Aortic Valve Dataset
The motivation for this research comes from a study, conducted by the Department of
Cardio-Thoracic Surgery of the Erasmus Medical Center in the Netherlands that includes
286 patients who received a human tissue valve in the aortic position in the hospital from
1987 until 2008 (Bekkers et al. 2011). Aortic allograft implantation has been widely used
for a variety of aortic valve or aortic root diseases. Initial reports on the use of either
fresh or cryopreserved allografts date from the early years of heart valve surgery. Major
advantages ascribed to allografts are the excellent hemodynamic characteristics as a valve
substitute; the low rate of thrombo-embolic complications, and, therefore, absence of the
need for anticoagulant treatment; and the resistance to endocarditis. A major disadvantage
of using human tissue valves, however is the susceptibility to (tissue) degeneration and need
for re-interventions. The durability of a cryopreserved aortic allograft is age-dependent,
leading to a high lifetime risk of re-operation, especially for young patients. Re-operations
on the aortic root are complex, with substantial operative risks, and mortality rates in the
range 4–12%.
In our study, a total of 77 (26.9%) patients received a sub-coronary implantation (SI) and
the remaining 209 patients a root replacement (RR). These patients were followed prospec-
tively over time with annual telephone interviews and biennial standardized echocardio-
graphic assessment of valve function until July 8, 2010. Echo examinations were scheduled
at 6 months and 1 year postoperatively, and biennially thereafter, and at each examina-
tion, echocardiographic measurements of aortic gradient (mmHg) were taken. By the end of
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follow-up, 1241 aortic gradient measurements were recorded with an average of 5 measure-
ments per patient (s.d. 2.3 measurements), 59 (20.6%) patients had died, and 73 (25.5%)
patients required a re-operation on the allograft. Following the discussion in Section 1, our
aim here is to use the existing data to construct a prognostic tool that will provide accurate
risk predictions for future patients from the same population, utilizing their baseline informa-
tion, namely age, gender and the type of operation they underwent, and their recorded aortic
gradient levels. The composite event re-operation or death was observed for 125 (43.7%)
patients, and the corresponding Kaplan-Meier estimator for the two intervention groups is
shown in Figure 1. We can observe minimal differences in the re-operation-free survival rates
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Figure 1: Kaplan-Meier estimates of the survival functions for re-operation-free survival for
the sub-coronary implantation (SI) and root replacement (RR) groups.
between sub-coronary implantation and root replacement, with only a slight advantage of
sub-coronary implantation towards the end of the follow-up. For the longitudinal outcome,
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Figure 2 depicts the subject-specific longitudinal profiles for the two intervention groups.
Because aortic gradient exhibits right skewness, we use the square root transform of aortic
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Figure 2: Subject-specific profiles for the square root aortic gradient separately for the sub-
coronary implantation (SI) and root replacement (RR) groups.
gradient. We observe considerable variability in the shapes of these trajectories, but there
are no systematic differences apparent between the two groups.
3 Joint Model Specification and Predictions
3.1 Submodels
Let T ∗i denote the true event time for the i-th subject (i = 1, . . . , n), Ci the censoring
time, and Ti = min(T
∗
i , Ci) the corresponding observed event time. In addition, we let
δi = I(T
∗
i ≤ Ci) denote the event indicator, with I(·) being the indicator function that takes
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the value 1 when T ∗i ≤ Ci, and 0 otherwise. For the longitudinal process, we let yi denote the
ni × 1 longitudinal response vector for the i-th subject, with element yil denoting the value
of the longitudinal outcome taken at time point til, l = 1, . . . , ni. Our aim is to postulate a
suitable joint model that associates these two processes.
Focusing on normally distributed longitudinal outcomes, we use a linear mixed-effects
model to describe the subject-specific longitudinal trajectories. Namely, we have
yi(t) = mi(t) + εi(t) = x
>
i (t)β + z
>
i (t)bi + εi(t),
bi ∼ N (0,D), εi(t) ∼ N (0, σ2),
(1)
where yi(t) denotes the value of the longitudinal outcome at any particular time point t,
xi(t) and zi(t) denote the time-dependent design vectors for the fixed-effects β and for the
random effects bi, respectively, and εi(t) the corresponding error terms that are assumed
independent of the random effects, and cov{εi(t), εi(t′)} = 0 for t′ 6= t. For the survival
process, we assume that the risk for an event depends on the true and unobserved value of
the marker at time t, denoted by mi(t) in (1). More specifically, we have
hi(t | Mi(t),wi) = lim
s→0
Pr{t ≤ T ∗i < t+ s | T ∗i ≥ t,Mi(t),wi}
/
s
= h0(t) exp
{
γ>wi + αmi(t)
}
, t > 0, (2)
where Mi(t) = {mi(s), 0 ≤ s < t} denotes the history of the true unobserved longitudinal
process up to t, h0(·) denotes the baseline hazard function, and wi is a vector of baseline
covariates with corresponding regression coefficients γ. Parameter α quantifies the associa-
tion between the true value of the marker at t and the hazard for an event at the same time
point. To complete the specification of the survival process we need to make appropriate
assumptions for the baseline hazard function h0(·). Typically in survival analysis this is left
unspecified. However, since our aim is to make subject-specific predictions of survival proba-
bilities, we use a smoother assumption for this function. We achieve this, while still allowing
for flexibility in the specification of h0(·) by using a B-splines approach. In particular, the
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log baseline hazard function is expressed as
log h0(t) = γh0,0 +
Q∑
q=1
γh0,qBq(t,v), (3)
where Bq(t,v) denotes the q-th basis function of a B-spline with knots v1, . . . , vQ and γh0
the vector of spline coefficients. Increasing the number of knots Q increases the flexibility in
approximating log h0(·); however, we should balance bias and variance and avoid overfitting.
A standard rule of thumb is to keep the total number of parameters, including the parameters
in the linear predictor in (2) and in the model for h0(·), between 1/10 and 1/20 of the total
number of events in the sample (Harrell 2001, Section 4.4). After the number of knots has
been decided, their location is based on percentiles of the observed event times Ti or of the
true event times {Ti : T ∗i ≤ Ci, i = 1, . . . , n} to allow for more flexibility in the region of
greatest density.
3.2 Estimation
For the estimation of the joint model’s parameters we follow the Bayesian paradigm and
derive posterior inferences using a Markov chain Monte Carlo algorithm (MCMC). The like-
lihood of the models is derived under the assumption that the vector of time-independent
random effects bi accounts for all interdependencies between the observed outcomes. That
is, given the random effects, the longitudinal and event time process are assumed indepen-
dent, and in addition, the longitudinal responses of each subject are assumed independent.
Formally we have,
p(yi, Ti, δi | bi,θ) = p(yi | bi,θ) p(Ti, δi | bi,θ), (4)
p(yi | bi,θ) =
∏
l
p(yil | bi,θ), (5)
where θ> = (θ>t ,θ
>
y ,θ
>
b ) denotes the full parameter vector, with θt denoting the parameters
for the event time outcome, θy the parameters for the longitudinal outcomes, and θb the
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unique parameters of the random-effects covariance matrix, and p(·) denotes an appropri-
ate probability density function. In addition, we assume that given the observed history
of longitudinal responses up to time s, the censoring mechanism and the visiting process
are independent of the true event times and future longitudinal measurements at t > s.
Under these assumptions, the likelihood contribution for the i-th subject conditional on the
parameters and random effects takes the form:
p(yi, Ti, δi | θ, bi) =
ni∏
l=1
p(yil | bi;θy) p(Ti, δi | bi;θt,β) p(bi;θb) (6)
∝
[
(σ2)−ni/2 exp
{
−
∑
l
(
yil − x>ilβ − z>ilbi
)2
/2σ2
}
×
[
exp
{∑
q
γh0,qBq(Ti,v) + γ
>wi + αmi(Ti)
}]δi
× exp
[
− exp(γ>wi)
∫ Ti
0
exp
{∑
q
γh0,qBq(s,v) + αmi(s)
}
ds
]
× det(D)−1/2 exp(−b>i D−1bi/2)],
where the intercept term γh0,0 from the definition of the baseline risk function (3) has been
incorporated into the design vector wi. The integral in the definition of the survival function
Si(t | Mi(t),wi) = exp
{
−
∫ t
0
h0(s) exp
{
γ>wi + αmi(s)
}
ds
}
, (7)
does not have a closed-form solution, and thus a numerical method must be employed for
its evaluation. Here we use a 15-point Gauss-Kronrod quadrature rule. For the parameters
θ we take standard prior distributions. In particular, for the vector of fixed effects of the
longitudinal submodel β, for the regression parameters of the survival model γ, for the vector
of spline coefficients for the baseline hazard γh0 , and for the association parameter α we use
independent univariate diffuse normal priors. For the variance of the error terms σ2 we take
an inverse-Gamma prior, while for covariance matrices we assume an inverse Wishart prior.
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3.3 Dynamic Individualized Predictions
Under the Bayesian specification of the joint model, presented in Section 3, we can derive
subject-specific predictions for either the survival or longitudinal outcomes (Yu et al. 2008;
Rizopoulos 2011, 2012). To put it more formally, based on a joint model fitted in a sam-
ple Dn = {Ti, δi,yi; i = 1, . . . , n} from the target population, we are interested in deriving
predictions for a new subject j from the same population that has provided a set of longitu-
dinal measurements Yj(t) = {yj(s); 0 ≤ s ≤ t}, and has a vector of baseline covariates wj.
The fact that biomarker measurements have been recorded up to t, implies survival of this
subject up to this time point, meaning that it is more relevant to focus on the conditional
subject-specific predictions, given survival up to t. In particular, for any time u > t we are
interested in the probability that this new subject j will survive at least up to u, i.e.,
pij(u | t) = Pr(T ∗j ≥ u | T ∗j > t,Yj(t),wj,Dn).
Similarly, for the longitudinal outcome we are interested in the predicted longitudinal re-
sponse at u, i.e.,
ωj(u | t) = E
{
yj(u) | T ∗j > t,Yj(t),Dn
}
.
The time-dynamic nature of both pij(u | t) and ωj(u | t) is evident because when new
information is recorded for patient j at time t′ > t, we can update these predictions to
obtain pij(u | t′) and ωj(u | t′), and therefore proceed in a time dynamic manner.
Under the joint modeling framework of Section 3, estimation of either pij(u | t) or ωj(u | t)
is based on the corresponding posterior predictive distributions, namely
pij(u | t) =
∫
Pr(T ∗j ≥ u | T ∗j > t,Yj(t),θ) p(θ | Dn) dθ,
for the survival outcome, and analogously
ωj(u | t) =
∫
E
{
yj(u) | T ∗j > t,Yj(t),θ
}
p(θ | Dn) dθ,
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for the longitudinal one. The calculation of the first part of each integrand takes full ad-
vantage of the conditional independence assumptions (4) and (5). In particular, we observe
that the first factor of the integrand of pij(u | t) can be rewritten by noting that:
Pr(T ∗j ≥ u | T ∗j > t,Yj(t),θ) =
∫
Pr(T ∗j ≥ u | T ∗j > t, bj,θ) p(bj | T ∗j > t,Yj(t),θ) dbj
=
∫
Sj
{
u | Mj(u, bj),θ
}
Sj
{
t | Mj(t, bj),θ
} p(bj | T ∗j > t,Yj(t),θ) dbj,
whereas for ωj(u | t) we similarly have:
E
{
yj(u) | T ∗j > t,Yj(t),θ
}
=
∫
E
{
yj(u) | bj,θ} p(bj | T ∗j > t,Yj(t),θ) dbj
= x>j (u)β + z
>
j (u)b¯
(t)
j ,
with
b¯
(t)
j =
∫
bj p(bj | T ∗j > t,Yj(t),θ) dbj.
Combining these equations with the MCMC sample from the posterior distribution of the
parameters for the original data Dn, we can devise a simple simulation scheme to obtain
Monte Carlo estimates of pij(u | t) and ωj(u | t). More details can be found in Yu et al.
(2008) and Rizopoulos (2011, 2012).
4 Functional Form
In ordinary proportional hazards models it has been long recognized that the functional
form of time-varying covariates influences the derived inferences; see, for example, Fisher
and Lin (1999) and references therein. In the joint modeling framework however, where the
longitudinal outcome plays the role of a time-dependent covariate for the survival process,
this topic has received much less attention. The two main functional forms that have been
primarily used so far in joint models include in the linear predictor of the relative risk
model (2) either the subject-specific means mi(t) from the longitudinal submodel or just the
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random effects bi (Henderson et al. 2000; Rizopoulos and Ghosh 2011). Nonetheless, in our
setting, where our primary interest is in producing accurate predictions, we expect that the
link between the longitudinal and event time processes to be important, and therefore it is
relevant to investigate if and how the accuracy of predictions is influenced by the assumed
functional form. This is motivated by the fact that there could be other characteristics of
the patients’ longitudinal profiles that are more strongly predictive for the risk of an event,
such as the rate of increase/decrease of the biomarker’s levels or a suitable summary of the
whole longitudinal trajectory.
In this section, we present a few examples of alternative formulations for the associa-
tion structure between the longitudinal outcome and the risk for an event. These different
parameterizations can be seen as special cases of the following general formulation of the
relative risk model:
hi(t) = h0(t) exp
[
γ>wi +α>f{t, bi,Mi(t)}
]
,
where f(·) is a time-dependent function that may depend on the random effects and on the
true longitudinal history, as approximated by the mixed-effects model, and α is a vector of
association parameters.
4.1 Time-Dependent Slopes
The standard formulation (2) postulates that the risk for an event at time t is associated
with parameter α measuring the strength of this association. Even though this is a very
intuitively appealing parameterization with a clear interpretation for α, it cannot distinguish
between patients who, for instance, at a specific time point have equal true marker levels,
but they may differ in the rate of change of the marker, with one patient having an increasing
trajectory and the other a decreasing one. An extension of (2) to capture such a setting has
been considered by Ye et al. (2008) who posited a joint model in which the risk depends on
both the current true value of the trajectory and the slope of the true trajectory at time t.
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More specifically, the relative risk survival submodel takes the form,
hi(t) = h0(t) exp
{
γ>wi + α1mi(t) + α2m′i(t)
}
, (8)
where m′i(t) = d{x>i (t)β+z>i (t)bi}/dt. The interpretation of parameter α1 remains the same
as in the standard parameterization (2). Parameter α2 measures the association between
the value of the slope of the true longitudinal trajectory at time t and the risk for an event
at the same time point, provided that mi(t) remains constant.
4.2 Cumulative Effects
A common characteristic of both (2) and (8) is that the risk for an event at any time t
is assumed to be associated with features of the longitudinal trajectory at the same time
point. However, in ordinary time-dependent Cox models several authors have argued that
this assumption is over-simplistic, and in many real settings we may benefit from allowing
the risk to depend on a more elaborate function of the history of the time-varying covariate
(Sylvestre and Abrahamowicz 2009). Extending this concept in the context of joint models,
we will account for the cumulative effect of the longitudinal outcome by including in the
linear predictor of the relative risk submodel the integral of the longitudinal trajectory from
baseline up to time t. More specifically, the survival submodel takes the form
hi(t) = h0(t) exp
{
γ>wi + α
∫ t
0
mi(s) ds
}
, (9)
where for any particular time point t, α measures the strength of the association between
the risk for an event at time point t and the area under the longitudinal trajectory up to the
same time t, with the area under the longitudinal trajectory taken as a suitable summary of
the whole marker history Mi(t) = {mi(s), 0 ≤ s < t}.
A feature of (9) is that it assigns the same weight on all past values of the longitudinal
trajectory. This may not be reasonable when biomarker values closer to t are considered
more relevant. An extension that allows placing different weights at different time points
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is to multiply mi(t) with an appropriately chosen weight function $(·) that places different
weights at different time points, i.e.,
hi(t) = h0(t) exp
{
γ>wi + α
∫ t
0
$(t− s)mi(s) ds
}
. (10)
A possible family of functions with this property are probability density functions of known
parametric distributions, such as the normal, the Student’s-t and the logistic. The scale
parameter in these densities and the degrees of freedom parameter in the Student’s-t density
can be used to tune the relative weights of more recent marker values compared to older
ones.
4.3 Shared Random Effects
As mentioned earlier, one of the standard formulations of joint models includes in the linear
predictor of the risk model only the random effects of the longitudinal submodel, that is,
hi(t) = h0(t) exp(γ
>wi +α>bi), (11)
where α denotes a vector of association parameters each one measuring the association be-
tween the corresponding random effect and the hazard for an event. This parameterization is
more meaningful when a simple random-intercepts and random-slopes structure is assumed
for the longitudinal submodel, in which case the random effects express subject-specific devi-
ations from the average intercept and average slope. Under this setting this parameterization
postulates that patients who have a lower/higher level for the longitudinal outcome at base-
line (i.e., intercept) or who show a steeper increase/decrease in their longitudinal trajectories
(i.e., slope) are more likely to experience the event. In that respect, this formulation shares
also similarities with the time-dependent slopes formulation (8).
A computational advantage of formulation (11) is that it is time-independent, and there-
fore leads to a closed-form solution (under certain baseline risk functions) for the integral
in the definition of the survival function (7). This facilitates computations since we do
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not have to numerically approximate this integral. However, an important disadvantage
of (11) emerges when polynomials or splines are used to capture nonlinear subject-specific
evolutions, in which case the random effects do not have a straightforward interpretation,
complicating in turn the interpretation of α. Nonetheless, in our setting, we are primarily
interested in predictions and not that much in interpretation, and thus we can consider (11)
even under an elaborate mixed model.
5 Bayesian Model Averaging
The previous section demonstrated that there are several choices for the link between the
longitudinal and event time outcomes. The common practice in prognostic modeling is to
base predictions on a single model that has been selected based on an automatic algorithm,
such as, backward, forward or stepwise selection, or on likelihood-based information criteria,
such as, AIC, BIC, DIC and their variants. However, what is often neglected in this procedure
is the issue of model uncertainty. For example, in the scenario that two models are correct,
model selection forces us to choose one of the models even if we are not certain which model
is true. In addition, with respect to predictions, there could be several competing models
that could offer almost equally good predictions or even that some models may produce more
accurate predictions for some subjects with specific longitudinal profiles, while other models
may produce better predictions for subjects whose profiles have other features. Here we
follow another approach and we explicitly take into account model uncertainty by combining
predictions under different association structures using Bayesian model averaging (BMA)
(Hoeting et al. 1999). We should stress that in our setting there is no concern in using
BMA, because we do not average parameters that possibly have different interpretations
under the different association structures, but rather predictions that maintain the same
interpretation whatever the chosen functional form.
Due to space limitations, we will only focus here on dynamic BMA predictions of survival
probabilities. BMA predictions for the longitudinal outcome can be produced with similar
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methodology. Following the definitions of Section 3.3, we assume that we have available data
Dn = {Ti, δi,yi; i = 1, . . . , n} based on which we fit M1, . . . ,MK joint models with different
association structures. Interest is in calculating predictions for a new subject j from the same
population who has provided a set of longitudinal measurements Yj(t) = {yj(s); 0 ≤ s ≤ t},
and has a vector of baseline covariates wj. We let Dj(t) = {Yj(t), T ∗j > t,wj} denote the
available data for this subject. The model-averaged probability of subject j surviving time
u > t, given her survival up to t is given by the expression:
Pr(T ∗j > u | Dj(t),Dn) =
K∑
k=1
Pr(T ∗j > u |Mk,Dj(t),Dn) p(Mk | Dj(t),Dn). (12)
The first term in the right-hand side of (12) denotes the model-specific survival probabilities,
derived as in Section 3.3, and the second term denotes the posterior weights of each of the
competing joint models. The unique characteristic of these weights is that they depend on
the observed data of subject j, in contrast to classic applications of BMA where the model
weights are the same for all subjects. This means that, in our case, the model weights
are both subject- and time-dependent, and therefore, for different subjects, and even for
the same subject but at different times points, different models may have higher posterior
probabilities. Hence, this framework is capable of better tailoring predictions to each subject
than standard prognostic models, because at any time point we base risk assessments on the
models that are more probable to describe the association between the observed longitudinal
trajectory of a subject and the risk for an event.
For the calculation of the model weights we observe that these are written as:
p(Mk | Dj(t),Dn) = p(Dj(t) |Mk) p(Dn |Mk) p(Mk)K∑`
=1
p(Dj(t) |M`) p(Dn |M`) p(M`)
,
where
p(Dj(t) |Mk) =
∫
p(Dj(t) | θk)p(θk |Mk) dθk
and p(Dn | Mk) is defined analogously. The likelihood part p(Dn | θk) is given by (6),
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whereas p(Dj(t) | θk) equals
p(Dj(t) | θk) = p(Yj(t) | bi,θk)Sj(t | bi,θk) p(bj | θk).
Thus, the subject-specific information in the model weights at time t comes from the available
longitudinal measurements Yj(t) but also from the fact that this subject has survived up
to t. Closed-form expressions for the marginal densities p(Dn | Mk) and p(Dj(t) | Mk) are
obtained by means of Laplace approximations (Tierney and Kadane 1986) performed in two-
steps, namely, first integrating out the random effects bi and then the parameters θk. The
details are given in the supplementary material. Finally, a priori we assume that all models
are equally probable, i.e., p(Mk) = 1/K, for all k = 1, . . . , K.
6 Analysis of the Aortic Valve Dataset
We return to the Aortic Valve dataset introduced in Section 2. Our aim here is to derive
a prediction tool that will utilize all recorded information of a patient to provide accurate
individualized predictions for both future aortic gradient levels and the risk of re-operation-
free survival. Following the discussion of Sections 4 and 5, we will compare predictions
under different association structures between the longitudinal and survival outcomes, with
the BMA predictions that are based on all association structures simultaneously.
We start by defining the set of joint models from which predictions will be calculated.
For the longitudinal process we allow a flexible specification of the subject-specific square
root aortic gradient trajectories using natural cubic splines of time. More specifically, the
linear mixed model takes the form
yi(t) = β1SIi + β2RRi + β3{B1(t, λ)× SIi}+ β4{B1(t, λ)× RRi}
+ β5{B2(t, λ)× SIi}+ β6{B2(t, λ)× RRi}
+ β7{B3(t, λ)× SIi}+ β8{B3(t, λ)× RRi}
+ bi0 + bi1B1(t, λ) + bi2B2(t, λ) + bi3B3(t, λ) + εi(t),
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where Bn(t, λ) denotes the B-spline basis for a natural cubic spline with boundary knots
at baseline and 19 years and internal knots at 2.1 and 5.5 years (i.e., the 33.3% and 66.6%
percentiles of observed follow-up times), SI and RR are the dummy variables for the sub-
coronary implantation and root replacement groups, respectively, εi(t) ∼ N (0, σ2) and bi ∼
N (0,D). For the survival process we consider five relative risk models, each positing a
different association structure between the two processes, namely:
M1 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + α1mi(t)
}
,
M2 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + α1mi(t) + α2m
′
i(t)
}
,
M3 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + α1
∫ t
0
mi(s)ds
}
,
M4 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + α1
∫ t
0
φ(t− s)mi(s)ds
}
,
M5 : hi(t) = h0(t) exp
(
γ1RRi + γ2Agei + γ3Femalei + α1bi0 + α2bi1 + α3bi2 + α4bi3
)
,
where the baseline hazard is approximated with splines, as described in Section 3.1, Female
denotes the dummy variable for females, and φ(·) denotes the probability density function of
the standard normal distribution. We fitted each of these joint models using a single chain
of 115000 MCMC iterations from which we discarded the first 15000 samples as burn-in. All
computations have been performed in R (version 2.15.2) and JAGS (version 3.3.0). Trace
and auto-correlations plots did not show any alarming indications of convergence failure.
Tables 1 and 2 in the supplementary material show estimates and the corresponding 95%
credible intervals for the parameters in the longitudinal and survival submodels, respectively.
We observe that the parameter estimates in the relative risk models show much greater
variability between the posited association structures than the parameters in the linear
mixed models. However, we should note that the interpretation of the regression coefficients
γ is not the same in all five models because we condition on different components of the
longitudinal process.
We continue with the calculation of dynamic predictions based on these five joint models.
To mimic the real-life use of a prognostic tool, we calculate predictions for three patients,
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namely Patients 20, 22 and 81, who have been excluded from the dataset we used to fit
the joint models. Patient 20 is a female of 64 years old and has received a sub-coronary
implantation, Patient 22 is a male of 53 and has also received a sub-coronary implantation,
and Patient 81 is a male of 39 and has undertaken a root replacement. The longitudinal
trajectories of square root aortic gradient for these patients are illustrated in Figure 3, from
which we see that Patients 20 and 22 show similar profiles with an initial drop in their
aortic gradient levels after the operation and up to about five years followed by a stable
increase for the next five years and a drop again. On the contrary, Patient 81 showed a
steady increase of aortic gradient for the duration of his follow-up. For each one of those
subjects we calculate dynamic predictions (i.e., a new prediction after each aortic gradient
measurement has been recorded) for both the longitudinal and survival outcomes based on
each of the five fitted joint models. In addition, following the methodology of Section 5, we
also calculate BMA dynamic predictions for each patient by taking weighted averages of the
predictions of the five joint models. We show the predictions of re-operation-free survival
probabilities for Patients 20 and 81 in Figures 4 and 5, respectively. The predictions for
Patient 22, and the predictions of future square root aortic gradient levels are presented in
Figures 1–4 in the supplementary material. Similarly to the results in Tables 1 and 2 in
the supplementary material, we observe that the predictions of survival probabilities seem to
be more sensitive to the assumed association structure than the predictions of future square
root aortic gradient levels. Much greater differences can be seen for Patient 81 who showed
a steeper increase in his aortic gradient levels than the other two patients. Regarding the
BMA predictions, it is interesting to note that they show some variability and they are not
always dictated by a single joint model. In particular, Table 1 presents the time-dependent
subject-specific BMA weights, from which some interesting observations can made. First,
only models M2 and M3 contribute in the BMA predictions of these three patients with the
weights of the other three models being practically zero. Second, we indeed observe that
the choice of the most appropriate model changes in time; for example, for Patient 20 and
using only the first measurement we observe that there is little to choose between models M2
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Figure 3: Longitudinal trajectories of square root aortic gradient for Patients 20, 22 and 81
who have been excluded from the analysis dataset, and for who we calculate predictions.
and M3, when the second measurement is observed then M2 dominates, whereas when the
third measurement is recorded prediction is based solely on model M3 (though predictions
based on the first two measurements are very similar from all five models, more variability
is observed for latter time points). Similar behavior is observed for the other two patients
as well. This convincingly demonstrates that it would be not optimal to base predictions on
a single model for all patients and during the whole follow-up.
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Figure 4: Dynamic predictions of re-operation-free survival for Patient 20 under the five
joint models along with the BMA predictions. Each panel shows the corresponding con-
ditional survival probabilities calculated after each of her longitudinal measurements have
been recorded.
7 Simulations
7.1 Design
We performed a series of simulations to evaluate the finite sample performance of the BMA
subject-specific predictions. The design of our simulation study is motivated by the set of
joint models fitted to the Aortic Valve dataset in Section 6. In particular, we assume 300
patients who have been followed-up for a period of 19 years, and were planned to provide
longitudinal measurements at baseline and afterwards at nine random follow-up times. For
the longitudinal process, and similarly to the model fitted in the Aortic Valve dataset, we
used natural cubic splines of time with two internals knots placed at 2.1 and 5.5 years, and
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Figure 5: Dynamic predictions of re-operation-free survival for Patient 81 under the five
joint models along with the BMA predictions. Each panel shows the corresponding condi-
tional survival probabilities calculated after each of his longitudinal measurements have been
recorded.
boundary knots placed at baseline and 19 years, i.e., the form of the model is as follows
yi(t) = β1Trt0i + β2Trt1i + β3{B1(t, λ)× Trt0i}+ β4{B1(t, λ)× Trt1i}
+ β5{B2(t, λ)× Trt0i}+ β6{B2(t, λ)× Trt1i}
+ β7{B3(t, λ)× Trt0i}+ β8{B3(t, λ)× Trt1i}
+ bi0 + bi1B1(t, λ) + bi2B2(t, λ) + bi3B3(t, λ) + εi(t),
where Bn(t, λ) denotes the B-spline basis for a natural cubic spline, Trt0 and Trt1 are the
dummy variables for the two treatment groups, εi(t) ∼ N (0, σ2) and bi ∼ N (0,D) with D
taken to be diagonal.
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Subject Year (Aort.Grad.)1/2 M1 M2 M3 M4 M5
20 2.9 4.0 0.00 0.43 0.57 0.00 0.00
3.9 3.6 0.00 1.00 0.00 0.00 0.00
4.9 0.0 0.00 0.02 0.98 0.00 0.00
7.0 2.6 0.00 0.00 1.00 0.00 0.00
8.4 3.7 0.00 0.99 0.01 0.00 0.00
10.3 4.0 0.00 0.00 1.00 0.00 0.00
12.1 4.6 0.00 0.57 0.43 0.00 0.00
14.2 3.6 0.00 0.88 0.12 0.00 0.00
22 3.1 2.8 0.00 0.95 0.05 0.00 0.00
4.2 2.4 0.00 1.00 0.00 0.00 0.00
5.3 1.7 0.00 0.00 1.00 0.00 0.00
8.3 2.2 0.00 1.00 0.00 0.00 0.00
10.8 3.0 0.00 1.00 0.00 0.00 0.00
13.1 4.2 0.00 0.01 0.99 0.00 0.00
15.0 4.0 0.00 1.00 0.00 0.00 0.00
17.3 2.6 0.00 0.67 0.33 0.00 0.00
81 0.3 3.2 0.00 1.00 0.00 0.00 0.00
1.3 3.6 0.00 0.84 0.16 0.00 0.00
3.3 5.0 0.00 1.00 0.00 0.00 0.00
5.3 7.4 0.00 0.17 0.83 0.00 0.00
7.1 9.8 0.00 0.19 0.81 0.00 0.00
10.6 10.0 0.00 0.99 0.01 0.00 0.00
Table 1: BMA posterior weights for the five joint models for each subject and after each
measurement.
For the survival process, we have assumed four scenarios, each one corresponding to
a different functional form for the association structure between the two processes. More
specifically,
Scenario I: hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1mi(t)
}
,
Scenario II: hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1mi(t) + α2m
′
i(t)
}
,
Scenario III: hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1
∫ t
0
mi(s)ds
}
,
Scenario IV: hi(t) = h0(t) exp
(
γ0 + γ1Trt1i + α1bi0 + α2bi1 + α3bi2 + α4bi3
)
,
with h0(t) = σtt
σt−1, i.e., the Weibull baseline hazard. The values for the regression coef-
ficients in the longitudinal and survival submodels, the variance of the error terms of the
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mixed model, the covariance matrix for the random effects, and the scale of the Weibull
baseline risk function are given in Section 3 of the supplementary material. Censoring times
were simulated from a uniform distribution in (0, tmax) with tmax set to result in about 45%
censoring in each scenario. For each scenario we simulated 200 datasets.
7.2 Results
Motivated by the Aortic Valve dataset to produce accurate risk predictions, but also from
previous experience regarding the robustness of predictions for the longitudinal outcome on
the assumed association structure, we have focused on dynamic predictions for the survival
outcome. More specifically, under each scenario and for each simulated dataset, we randomly
excluded ten subjects whose event times were censored (it is more meaningful to calculate
predictions for those individuals since they have not experienced the event yet), and in the
remaining patients, we fitted five joint models. The longitudinal submodel was the same
as the one we simulated from. For the survival process we assumed relative risk submodels
with: the current value term (as in Scenario I), the current value and current slope terms (as
in Scenario II), the cumulative effect (as in Scenario III), the weighted cumulative effect (10)
with weight function the probability density function of the standard normal distribution,
and only including the random effects (as in Scenario IV). Because the aim of this simulation
study was to investigate how the different association structures affect predictions, we also
assumed the same Weibull baseline hazard function from which we simulated the data and
not the B-spline approximated baseline hazard (3) presented in Section 3.1.
Based on the five fitted joint models, we calculated predictions for each of the ten subjects
we have originally excluded, at ten equidistant time points between their last available
longitudinal measurement and the end of follow-up. These predictions were calculated under
the true model for each scenario, BMA including all five models, and BMA based on four
models without including the true one for the specific scenario. These predicted survival
probabilities were then compared with the gold standard survival probabilities, calculated
as Sj
{
u | Mj(u, bj),θ
}
/Sj
{
t | Mj(t, bj),θ
}
, using the true parameter values and the true
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values of the random effects for the subjects we excluded. In each simulated dataset and for
each of the ten subjects, we calculated root mean squared prediction errors (RMSEs) between
the gold standard survival probabilities and the predictions under the three methods. The
RMSEs over all the subjects from the 200 datasets are shown in Figure 6. For all scenarios
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Figure 6: Simulation results under the four scenarios based on 200 datasets. Each box-
plot shows the distribution of the root mean squared predictions error of the corresponding
method to compute predictions (i.e., based on the true model, BMA including the true model
and BMA without the true model) versus the gold standard.
we observe that in practice the BMA subject-specific predictions perform very well against
the corresponding predictions from the true model. The greatest differences are observed in
Scenario IV in which the BMA predictions seem to considerably outperform the true model
predictions. A more careful examination of this scenario showed that this behavior was due
to the fact that all models produced on average accurate predictions, but the predictions
from the true model were much more variable than ones from the other models. In addition,
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for the scenarios we considered in this study, it seems that BMA works equally well whether
or not the true model is included in the list of the models that are averaged. This is a
promising result because it suggests that BMA-based predictions could ‘protect’ against a
misspecification of the association structure between the two processes.
8 Discussion
This paper illustrated how dynamic predictions from joint models with different association
structures can be optimally combined using Bayesian model averaging. The novel feature of
this approach is that the weights for combing predictions depend on the recorded information
for the subject for whom predictions are of interest. Thus, for different subjects and even for
the same subject but at different follow-up times, different models may have higher weights.
This explicitly accounts for model uncertainty and acknowledges that a single prognostic
model may not be adequate for quantifying the risk of all patients. Our simulation study
showed that BMA predictions perform very well in comparison with predictions from the
true model, even if the true model is not included in the list of models that are averaged.
This gives us more confidence in trusting BMA for deriving predictions for future patients
from the Aortic Valve study population based on the five joint models we have considered.
In our developments we have considered a simple joint model for a single longitudinal
outcome and one time-to-event. However, often in longitudinal studies several outcomes
are recorded on each patient during follow-up. For example, for the patients enrolled in
the Aortic Valve study also aortic regurgitation was recorded, which is another measure of
valve function. Hence it would be of interest to investigate whether by considering both
longitudinal biomarkers we could improve the accuracy of predictions. In addition, in our
analysis we have considered the composite event re-operation or death (whatever comes
first), but for the treating physicians it could be of interest to have separate risk estimates
for the two events. Based on recent advances in joint modeling that include joint models for
multiple markers and multiple event times (Huang et al. 2011; Rizopoulos and Ghosh 2011;
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Liu and Huang 2009), our ideas could be relatively easily extended to these more elaborate
cases. The challenge in such settings will be the high dimensionality of the model space.
This is because the number of possible combinations of association structures between the
longitudinal and the survival processes grows exponentially with the number of outcomes.
A topic that we have partially addressed in this paper, but which is of high relevance for
the practicality of prognostic models concerns the external validation of the derived predic-
tions in terms of both discrimination and calibration. In particular, from our simulations
we saw that the BMA predictions perform satisfactorily compared to the predictions using
the true model, but this does not answer the question of how accurately the longitudinal
outcome can predict the survival one or if it can discriminate between subjects of low and
high risk. In standard survival analysis there has been a lot of research at these two fronts
(see e.g., Zheng and Heagerty 2007; Gerds and Schumacher 2006, and references therein), but
within the joint modeling framework relatively little work has been done (Rizopoulos 2011;
Proust-Lima and Taylor 2009). Theoretically, all standard measures for calibration (e.g.,
Brier score) and discrimination (time-dependent sensitivity, specificity and ROC curves) can
be defined for joint models, but their estimation is more challenging.
9 Supplementary Material
Supplementary material are available in SuppPredParam.pdf, and include Section 1: Fig-
ures and Tables with results from the analysis of the Aortic Valve dataset; Section 2:
Details on the Laplace approximations to calculate p(Dn | Mk) and p(Dj(t) | Mk); Section
3: Details on the simulation settings.
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